| Literature DB >> 15256832 |
Magnus Simrén1, John Brazier, Georges Coremans, Michel Dapoigny, Stefan A Müller-Lissner, Fabio Pace, André J P M Smout, Reinhold W Stockbrügger, Morten H Vatn, Peter J Whorwell.
Abstract
Quality of life is reduced in patients with irritable bowel syndrome, and the costs for this disease are substantial to society. During a meeting in London, UK, the IBiS club reviewed the literature on these subjects. Drawbacks and advantages with existing instruments to assess quality of life and costs were discussed and the clinical and scientific relevance of the current knowledge was assessed. A summary from the meeting is presented in this paper.Entities:
Mesh：
Year: 2004 PMID： 15256832 DOI： 10.1159/000079846
Source DB: PubMed Journal: Digestion ISSN： 0012-2823 Impact factor: 3.216